APA (7th ed.) Citation

(2019). Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial.

Chicago Style (17th ed.) Citation

Dulaglutide and Cardiovascular Outcomes in Type 2 Diabetes (REWIND): A Double-blind, Randomised Placebo-controlled Trial. 2019.

MLA (8th ed.) Citation

Dulaglutide and Cardiovascular Outcomes in Type 2 Diabetes (REWIND): A Double-blind, Randomised Placebo-controlled Trial. 2019.

Warning: These citations may not always be 100% accurate.